Destiny Pharma PLC unveils further positive results for c-difficile treatment as market research points to its commercial potential

NTCD-M3, which scientists are readying to period III clinical trials, was the subject to a different…

Destiny Pharma – Neil Clark, CEO (AIM:DEST) One2One Virtual Forum 10th December 2021

Destiny Pharma PLC (Purpose:DEST) (Destiny Pharma PLC (Purpose:DEST)) is a clinical stage, modern biotechnology organization focused…

Destiny Pharma PLC looks to build on the progress made with its two key assets

The enterprise is blazing a trail in the infection arena and reckons it has two possible…

Destiny Pharma PLC teams up with US Department of Veterans Affairs to find ‘new attributes’ for its next-generation antibiotic

NTCD-M3 is being developed to combat Clostridioides difficile infections (CDI) in the gut () said it…

White House says data is one key to improving pharma supply chain resilience

The White Home and many federal organizations on Tuesday introduced a series of plan tips for…

Destiny Pharma PLC making significant strides towards phase III evaluation of potential breakthrough C.diff treatment

CEO Neil Clark explained: “We have manufactured important progress considering the fact that closing the £10.4mln…

Pharma firms cut Remdesivir injection prices on govt intervention: NPPA

Rates of remdesivir injection have been voluntarily curtailed by many drug businesses on the intervention of…

Natco Pharma to launch pheromone product to control Pink Bollworm in cotton crop

Natco Pharma Ltd is panning to start its first Environmentally friendly Label Pheromone merchandise for Successful…

Buffett bets on big pharma and bails on banks

Mr Buffett’s company had stakes valued at more than $1.8bn each in AbbVie, Bristol-Myers Squibb and…

Sun Pharma surges 4{744e41c82c0a3fcc278dda80181a967fddc35ccb056a7a316bb3300c6fc50654}, hits 52-week high; stock rallies 76{744e41c82c0a3fcc278dda80181a967fddc35ccb056a7a316bb3300c6fc50654} from March-low

Shares of Sunshine Pharmaceutical Industries surged all over four for each cent to strike a contemporary…